Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fremanezumab, ATC N02CD03

This is not an open procedure, but a so-called open-house model! The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded under the open-house model do not fall under procurement law due to the lack of a selection decision. The use of this form does not involve submission to procurement regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active substance Fremanezumab, ATC N02CD03, under § 130c (1) SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility criteria listed below the opportunity to conclude identical and non-individually negotiable discount agreements. The earliest possible contract start date is 01.04.2026, and all contracts end on 31.03.2028. A contract can be concluded at any time during this period, but at the latest by 03.02.2028. The contracts can be terminated with one month's notice to the end of the month. If a nationwide or state-specific rebate contract for medicines with the subject matter of the contract comes into force, the open-house agreements will automatically cease to apply for the corresponding term. A contract will be concluded with all interested pharmaceutical companies that prove their eligibility by means of a completed and signed self-declaration of reliability. The pharmaceutical company must submit the completed and signed (the authorisation of the signatory(s) must be evident from the commercial register extract, otherwise a power of attorney must be submitted) contract, together with the completed and signed annex "Specification of the contract medicines" and the completed and signed self-declaration of reliability. The documents can be submitted EITHER IN WRITING by hand signed OR ELECTRONICALLY with a qualified electronic signature. Documents signed by hand in writing must be sent in duplicate original to the following address: AOK Bayern - Die Gesundheitskasse Vergabestelle SGB V ZE25 open-house Rabattverträge Carl-Wery-Str. 28 81739 München ELECTRONIC documents with a qualified electronic signature must be submitted via the communication area in the tendering portal www.dtvp.de. If complete and correct documents are received by the 3rd of each month, the contract will commence on the first of the following month, otherwise on the first of the month after next. In the case of documents signed by hand in writing, the complete, completed and signed documents must be sent in advance as a scan to the e-mail address [email protected] or via the communication area in the tendering portal www.dtvp.de in a timely manner, if the complete and correct original documents in paper form are received by the AOK Bayern, Vergabestelle, by the 10th of the month. Please note the completion instructions, which are available under www.dtvp.de with the tender documents. Interested pharmaceutical companies can request the release of the tender documents in the project room for the open-house procedure on the portal www.dtvp.de. A link to the portal is included in this notice. Only pharmaceutical companies are considered as potential contractual partners. The documents for the open-house procedure will be released exclusively to pharmaceutical companies as potential contractual partners and must be treated as strictly confidential. By applying for the release, the companies confirm the confidential treatment of the documents.